Company Filing History:
1 out of 832,843 Years Active: 1979
Title: Edna Oppenheimer: Innovator in Antiarrhythmic Compounds
Introduction
Edna Oppenheimer is a notable inventor based in Tel Aviv, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic agents. Her innovative work has led to the creation of a compound that holds promise for treating heart conditions.
Latest Patents
Oppenheimer holds a patent for an antiarrhythmic compound known as quinuclidine carboxylic acid xylidide. This invention relates to the compound 2-6-xylidide of quinuclidine-3-carboxylic acid and its pharmaceutically acceptable salts, such as the hydrochloride. These compounds have been found to be effective antiarrhythmic agents. The patent also details the production method for this compound, which involves reacting quinuclidine carboxylic acid in anhydrous chloroform and oxalyl chloride with dimethylaniline. The process yields the desired compound in high purity and yield.
Career Highlights
Throughout her career, Edna Oppenheimer has demonstrated a commitment to advancing medical science through her innovative research. Her work has not only contributed to the understanding of antiarrhythmic agents but has also paved the way for further research in related compounds.
Collaborations
Oppenheimer has collaborated with notable colleagues in her field, including Eliezer Kaplinsky and Sasson Cohen. These partnerships have enhanced her research and contributed to the successful development of her patented compounds.
Conclusion
Edna Oppenheimer's contributions to the field of pharmaceuticals, particularly in antiarrhythmic compounds, highlight her role as an innovative inventor. Her work continues to impact the medical community and offers hope for advancements in heart disease treatment.